NL-OMON37801
Completed
Phase 4
Cross-sectional study of 24-hours blood pressure measures and left ventricular mass using echocardiograms in late adolescents and adults with ADHD. - ADDUCE: blood pressure and left ventrikel mass in ADHD.
niversitair Medisch Centrum Sint Radboud0 sites320 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Bloeddruk
- Sponsor
- niversitair Medisch Centrum Sint Radboud
- Enrollment
- 320
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Target group:
- •Patients with ADHD according to DSM\-IV criteria (any subtype), based on clinical diagnosis, and confirmed by a structured interview \[depending on local procedures: ADHD module of the K\-SADS (Kaufman et al., 2000\) or CAADID (Conners Adult ADHD Diagnostic Interview for DSM\-IV) (www.mhs.com/) or DIVA (Diagnostic Interview for Adult ADHD) (www.divacenter.eu/Content/Downloads/DIVA\_2\.pdf).
- •Aged between 15 and 25 years.
- •Any comorbidity is allowed.
- •Any comedication is allowed.
- •Treated with methylphenidate (IR or ER preparations) for 3 years or longer, continuously.;Note: we will attempt to recruit at least 50% of the participants of the target group being treated continuously for 3 years with a minimum effective dose of 0\.5 mg methylphenidate /kg/day). Being treated continuously means being prescribed methylphenidate continuously but may include the presence of drug holidays. We will measure adherence by asking questions about drug holidays and % of the overall dose taken. We will allow for some variation in dosages prescribed to be able to analyze dose\-response relationships.;Control group:
- •Patients with ADHD according to DSM\*IV criteria (any subtype), based on clinical diagnosis.
- •Aged between 15 and 25 years.
- •Any comorbidity is allowed.
- •Any comedication is allowed.
Exclusion Criteria
- •All Groups: Treatment with dexamfetamine or atomoxetine.
- •ADHD controls: Treatment with methylphenidate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A comparison of twenty-four-hour blood pressure control between candesartan and other ARBs estimated by the ambulatory blood pressure monitoringessential hypertensionJPRN-UMIN000003684Department of Integrated Medicine, Ehime University Graduate Schoolof Medicine50
Completed
Not Applicable
Assessment of time of day of blood pressure-lowering treatment by home blood pressure monitor in Japanese diabetic patients with hypertensiodiabetes mellitus, hypertensionJPRN-UMIN000008748Dept. of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University50
Completed
Not Applicable
octurnal blood pressure and nocturnal blood pressure fluctuations associated with the severity of obstructive sleep apneaG47.31DRKS00024087Augusta-Krankenhaus- akademisches Lehrkrankenhaus der Universität Düsseldorf, Abteilung Kardiologie548
Recruiting
Not Applicable
Intra-day blood pressure fluctuation and vascular complications in type 2 diabetesType 2 diabetesJPRN-UMIN000035266Shonan Fujisawa Tokushukai Hospital, Department of Endocrinology and Metabolism1,000
Recruiting
Not Applicable
Effect of blood pressure variability and nocturnal hypertension on hypertension-mediated organ damage and cardiovascular disease in elderly patients with hypertensioDiseases of the circulatory systemKCT0007196Chungbuk National University Hospital1,300